| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1850 | 2020 |
| Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium P Grivas, AR Khaki, TM Wise-Draper, B French, C Hennessy, CY Hsu, ... Annals of oncology 32 (6), 787-800, 2021 | 292 | 2021 |
| COVID-19 and cancer: current challenges and perspectives Z Bakouny, JE Hawley, TK Choueiri, S Peters, BI Rini, JL Warner, ... Cancer cell 38 (5), 629-646, 2020 | 267 | 2020 |
| Validating drug repurposing signals using electronic health records: a case study of metformin associated with reduced cancer mortality H Xu, MC Aldrich, Q Chen, H Liu, NB Peterson, Q Dai, M Levy, A Shah, ... Journal of the American Medical Informatics Association 22 (1), 179-191, 2015 | 253 | 2015 |
| Combining billing codes, clinical notes, and medications from electronic health records provides superior phenotyping performance WQ Wei, PL Teixeira, H Mo, RM Cronin, JL Warner, JC Denny Journal of the American Medical Informatics Association 23 (e1), e20-e27, 2016 | 207 | 2016 |
| The evolving use of electronic health records (EHR) for research E Kim, SM Rubinstein, KT Nead, AP Wojcieszynski, PE Gabriel, ... Seminars in radiation oncology 29 (4), 354-361, 2019 | 174 | 2019 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 173 | 2021 |
| Utilization of COVID-19 treatments and clinical outcomes among patients with cancer: a COVID-19 and Cancer Consortium (CCC19) cohort study DR Rivera, S Peters, OA Panagiotou, DP Shah, NM Kuderer, CY Hsu, ... Cancer discovery 10 (10), 1514-1527, 2020 | 143 | 2020 |
| Systematic review of infectious events with the Bruton tyrosine kinase inhibitor ibrutinib in the treatment of hematologic malignancies BF Tillman, JM Pauff, G Satyanarayana, M Talbott, JL Warner European Journal of Haematology 100 (4), 325-334, 2018 | 136 | 2018 |
| Use of natural language processing to extract clinical cancer phenotypes from electronic medical records GK Savova, I Danciu, F Alamudun, T Miller, C Lin, DS Bitterman, ... Cancer research 79 (21), 5463-5470, 2019 | 135 | 2019 |
| SMART on FHIR Genomics: facilitating standardized clinico-genomic apps G Alterovitz, J Warner, P Zhang, Y Chen, M Ullman-Cullere, D Kreda, ... Journal of the American Medical Informatics Association 22 (6), 1173-1178, 2015 | 132 | 2015 |
| A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer AH Wagner, B Walsh, G Mayfield, D Tamborero, D Sonkin, K Krysiak, ... Nature genetics 52 (4), 448-457, 2020 | 117 | 2020 |
| Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal I de Bruijn, R Kundra, B Mastrogiacomo, TN Tran, L Sikina, T Mazor, X Li, ... Cancer research 83 (23), 3861-3867, 2023 | 94 | 2023 |
| Crowdsourcing a crisis response for COVID-19 in oncology A Desai, J Warner, N Kuderer, M Thompson, C Painter, G Lyman, ... Nature cancer 1 (5), 473-476, 2020 | 93 | 2020 |
| COVID-19 vaccination and breakthrough infections in patients with cancer AL Schmidt, C Labaki, CY Hsu, Z Bakouny, N Balanchivadze, SA Berg, ... Annals of oncology 33 (3), 340-346, 2022 | 91 | 2022 |
| Erlotinib at a dose of 25 mg daily for non-small cell lung cancers with EGFR mutations WL Yeo, GJ Riely, BY Yeap, MW Lau, JL Warner, K Bodio, MS Huberman, ... Journal of Thoracic Oncology 5 (7), 1048-1053, 2010 | 89 | 2010 |
| Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics … P Horak, M Griffith, AM Danos, BA Pitel, S Madhavan, X Liu, C Chow, ... Genetics in Medicine 24 (5), 986-998, 2022 | 88 | 2022 |
| Integrating cancer genomic data into electronic health records JL Warner, SK Jain, MA Levy Genome medicine 8, 1-13, 2016 | 84 | 2016 |
| Beyond histology: translating tumor genotypes into clinically effective targeted therapies CB Meador, CM Micheel, MA Levy, CM Lovly, L Horn, JL Warner, ... Clinical Cancer Research 20 (9), 2264-2275, 2014 | 80 | 2014 |
| A systematic review of the factors predicting the interest in cosmetic plastic surgery P Milothridis, L Pavlidis, AB Haidich, E Panagopoulou Indian Journal of Plastic Surgery 49 (03), 397-402, 2016 | 78 | 2016 |
Joshua C. DennyCEO, All of Us Research Program在 nih.gov 的电子邮件经过验证
